Pharming Group N.V.: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Apr 4, 2024 and accepted by EDGAR at Apr 4, 2024, 08:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $245.3m | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $25.2m | ifrs-full:CostOfSales |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $220.1m | ifrs-full:GrossProfit |
| Operating income | 12 months2023-01-01 to 2023-12-31 | −$5.4m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2023-01-01 to 2023-12-31 | −$1.5m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −$0.02 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −$0.02 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | −$17.3m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $1.4m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2023-12-31 | $61.7m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2023-12-31 | $316.3m | ifrs-full:CurrentAssets |
| Total assets | At period end2023-12-31 | $462.9m | ifrs-full:Assets |
| Current liabilities | At period end2023-12-31 | $78.0m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2023-12-31 | $218.8m | ifrs-full:Equity |
| Shares outstanding | At period end2023-12-31 | 671,073,243 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001828316-24-000008. Last ingested by Listed: Nov 6, 2026, 11:08 ET. Listed shows no prices and gives no investment advice.